רקומבינאט IU 1000

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

Dostupno od:

TEVA MEDICAL MARKETING LTD.

ATC koda:

B02BD02

Farmaceutski oblik:

POWDER FOR SOLUTION FOR INJECTION

Administracija rute:

I.V

Proizveden od:

BAXTER S.A., BELGIUM

Terapijska grupa:

COAGULATION FACTOR VIII

Terapijske indikacije:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Datum autorizacije:

2010-07-01